Is Complete Response Enough? An Expert Look Towards the Future of Higher-Risk MDS Treatment - European Medical Journal

Is Complete Response Enough? An Expert Look Towards the Future of Higher-Risk MDS Treatment

Hematology

This satellite symposium discusses current key topics in higher-risk MDS, including treatment outcome measures, latest data on new agents in clinical development, and IPSS-M scoring. At the end of the discussion portion, the experts debate featured subjects in higher-risk MDS.

This satellite symposium was sponsored by Novartis

Topics in focus:

  • Overview of Higher-Risk MDS Key Topics in Focus
  • Beyond a Complete Response: Achieving Durable Outcomes for Patients With HR-MDS
  • Personalized Approaches to Treating HR-MDS With Novel Combinations
  • Debates
  • Question & Answer

Faculty:

Andrew Wei, MBBS, PhD
Peter MacCallum Cancer Centre and Royal Melbourne Hospital
Melbourne, Australia

Stef Meers, MD, PhD
AZ Klina
Antwerp, Belgium

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>